Revolution Medicines (RVMD) Stock Price, Quote, News & History | Benzinga

Revolution Medicines Inc (RVMD) Stock Price, Quote, News & History

RVMDNASDAQ

Trade with Public

Trade with Public

$216.00

4.001.89%

At close: Aug 18, 5:00 PM EST

$213.88

-2.12-0.98%

After Hours: 6:23 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$209.15

Close

$216.00

Volume / Avg.

1.65M / 2.57M

Day Range

$209.09 - $216.72

52 Wk Range

35.42 - 215.97

Market Cap

$45.84B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

70

Short Interest

5.68%

Days to Cover

6.28

Recent Revolution Medicines, Inc. News

Revolution Medicines' Pancreatic Cancer Pill Doubles Survival, Cuts Death Risk 60% in Trial As Stock Sits Near All-Time Highs

Few cancers have proven as difficult to treat as pancreatic cancer, making any sign of a survival breakthrough a major event for both patients and investors.

[email protected]

GraniteShares Files High-Octane 2X ETFs Tied To Nuclear, AI, Biotech Momentum Stocks

GraniteShares filed for 3 new 2x ETFs tied to XE, MAIR, and RVMD, offering daily leveraged exposure to nuclear, AI, and biotech themes.

Chandrima Sanyal

Stanley Druckenmiller Dumps Amazon And Alphabet While Loading Up On Commodities, Argentina And Biotech

Stanley Druckenmiller cut Amazon, exited Alphabet while increasing bets on Argentina, commodities, semiconductors, biotech stocks during Q1.

Surbhi Jain

Cancer Centers Race To Access Revolution Medicines' Pancreatic Cancer Treatment: Report

Cancer centers race to access Revolution Medicines' pancreatic cancer drug after trial data showed survival doubled.

Vandana Singh

Stock Market Today: S&P 500 Drops Amid Tech Sell-Off, Oil Climbs To $100 On Hormuz Drama

Tech stocks slide as OpenAI's user growth miss reignites AI capex skepticism, while oil rallies above $99 and the Fed's two-day meeting kicks off.

Piero Cingari

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-1.58B

Investing Cash Flow (TTM)

-1.21B

Financing Cash Flow (TTM)

3.26B

Free Cash Flow (TTM)

-1.59B

Capital Expenditure (TTM)

-10.64M

Net Change in Cash (TTM)

471.13M

Analyst Trends and Forecast

12

Apr

6

1

May

6

Jun

6

Jul

6

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$42.14B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

17.43

Earnings Yield % (TTM)

-4.18%

Earnings Yield % (FWD)

-4.14%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$12.16

Company Debt

Total Debt

$487.43M

LT Debt

$487.43M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$815.44M

Debt to Equity

0.25

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$209.15

Close

$216.00

Volume / Avg.

1.65M / 2.57M

Day Range

$209.09 - $216.72

52 Wk Range

35.42 - 215.97

Market Cap

$45.84B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

70

Short Interest

5.68%

Days to Cover

6.28

About

Sector

Health Care

Industry

Biotechnology

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacolog...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Revolution Medicines (RVMD) stock?

A

You can purchase shares of Revolution Medicines (NASDAQ:RVMD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Revolution Medicines (RVMD) competitors?

A

Other companies in Revolution Medicines’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Revolution Medicines (RVMD) stock?

A

Revolution Medicines has a consensus price target of $145.04.

Q

What is the current price for Revolution Medicines (RVMD)?

A

The stock price for Revolution Medicines (NASDAQ: RVMD) is $213.88 last updated August 18, 2026 at 6:23 PM EDT.

Q

Does Revolution Medicines (RVMD) pay a dividend?

A

There are no upcoming dividends for Revolution Medicines.

Q

When is Revolution Medicines (NASDAQ:RVMD) reporting earnings?

A

Revolution Medicines does not have any upcoming earnings scheduled.

Q

Is Revolution Medicines (RVMD) going to split?

A

There is no upcoming split for Revolution Medicines.

Q

What sector and industry does Revolution Medicines (RVMD) operate in?

A

Revolution Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.